tner and legal counsel to the RIC since its inception in the Fall 2021. Various Buchanan lawyers have been instrumental in the establishment of the RIC as a 501(c)(6) non-profit entity, and in guiding strategic planning initiatives. Law firm attorneys in addition to Reig who are supporting the consortium include Carrie Amezcua (Antitrust), Richard DiStefano (Corporate), Trisha Klan (FDA/Biotech/Life Sciences), Stanley Marciniak, III (Corporate), Natalie Oehlers (FDA/Biotech/Life Sciences), Jason Parish (Antitrust), Duane Stewart (Trademark/Copyright), and Marc Tepper (Insurance). On the administrative side, Buchanan’s Steven “Stevo” Anthos is the lead liaison with the conso...

In this series, designed for experienced pharma professionals and executives, Buchanan professionals will tackle critical issues to help you navigate the Pharma Product Lifecycle. In each session, we will dive into a specific phase of the lifecycle, provide attendees with the latest pharma updates and cover trends happening within the FDA and the industry in general. For the third session, "Finding Capital and Controlling Your Agreements" moderator, Rocky Rodriguez welcomes an esteemed set of panelists.  Richard DiStefano, Shareholder - Corporate, Buchanan Ingersoll and Rooney  Daniel Geffken, Founder and Managing Director, Danforth Advisors Joe Lee, Executive ...

to help TerraVida with this transaction,” said Joe Centeno, Shareholder and Co-Chair of Buchanan’s Labor & Employment section. “TerraVida has built a remarkable organization that is a market leader in Pennsylvania and will be a valuable addition to the Verano portfolio.” The Buchanan team included Brian North, Richard DiStefano, Shareholders in the Corporate section, Joe Centeno, John Warner, Shareholder in the Tax section, Andrew Giorgione, Shareholder in the Government Relations group, and Audrey Distler, Associate in the Corporate section....

The New York Law Journal published "Buchanan Ingersoll Makes Two New Additions in New York," highlighting the recent hire of Richard DiStefano in our Corporate section and Marc Adler in our Intellectual Property section.The article speaks to the larger growth of our New York office and details Rich's aim to broaden the Corporate and Securities group and work with emerging companies as a part of Buchanan Labs, as well as Marc's role in expanding our patent and trade secret management services....

Law360 wrote about Buchanan's recent hire of Richard DiStefano, highlighting his interest in Buchanan Labs in "Buchanan Ingersoll Hires Blank Rome Transactional Atty."...

NEW YORK – October 30, 2017 – Buchanan Ingersoll & Rooney continues to expand its Corporate section, specifically its public company practice, with the addition of Richard DiStefano, a shareholder in the firm’s New York office. DiStefano works with public and private companies, advising on corporate and securities matters. His experience cuts across a variety of industries, including financial services, retail, marketing, media and entertainment, beverage, personal care, nutritional supplements and medical device businesses. “As we continue to add depth to our public company practice, we are delighted to have Rich as part of our team. Rich has a distinctive abili...